Compare Bumble Inc (BMBL) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bumble Inc vs Recursion Pharmaceuticals Inc — how do they compare? Bumble Inc trades at $2.82 (market cap $366.87M), while Recursion Pharmaceuticals Inc trades at $3.37 (market cap $1.81B). The key difference: Recursion Pharmaceuticals Inc is far larger — about 4.9× Bumble Inc's market cap, and Recursion Pharmaceuticals Inc is trading nearer its 52-week high, Bumble Inc nearer its low. Which is the better fit depends on your goals.
| BMBL | RXRX | |
|---|---|---|
Market Cap | $366.87M | $1.81B |
Sector | Technology | Health |
52-Week High | $7.17 | $6.79 |
52-Week Low | $2.70 | $2.84 |
Enterprise Value | $672.73M | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bumble Inc
Bumble Inc is engaged in offering online dating services. The company operates two apps, Bumble and Badoo, where users come on a monthly basis to discover new people and connect with each other.
Read more on BMBL →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
